drugset / Trial / NCT06314724
Immunogenicity and Safety of Varicella Vaccine, Live in Healthy Children Aged 12~15 Months in the Philippines
RandomizedParallel-groupQuadruple-blindPrevention
Summary
This is a Phase Ⅲ, randomized, double-blind, active-controlled study to assess the immunogenicity and safety of the varicella vaccine,Live (hereinafter referred to as "varicella vaccine")manufactured by Sinovac (Dalian) Vaccine Technology Co., LTD.(hereinafter referred to as "Sinovac").
Timeline
- Start
- 2024-02-29
- Primary completion
- 2024-09-06
- Completion
- 2024-09-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Varicella vaccine | Vaccine | — | Subcutaneous |
| Comparator | Varivax | Vaccine | — | Subcutaneous |